3 Top Stocks to Buy in December

Keith Speights has positions in Amazon, MercadoLibre, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Amazon, MercadoLibre, TransMedics Group, and Vertex Pharmaceuticals.
The Manila Times

Johnson & Johnson receives European Commission approval of IMAAVY® (nipocalimab), a new FcRn blocker offering sustained disease control in a broad population of people living ...

Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...
Le Lézard

Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio

Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...